The global market for continuous glucose monitoring (CGM) devices was worth $165.8 million in 2010 and $183.7 million in 2011. This market is projected to reach $356.5 million by 2016, with a five-year compound annual growth rate (CAGR) of 14.2% from 2011 through 2016.
The market for transmitters and receivers was $83.4 million in 2011 and is expected to increase to $159.3 million by 2016, at a CAGR of 13.8%.
The market for glucose sensors was $76 million in 2011 and is expected to increase to $140.9 million by 2016, at a CAGR of 13.1%.
GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS BY
PRODUCT CATEGORY, 2009-2016 ($ MILLIONS)
Source: BCC Research
This report provides a comprehensive analysis of the continuous glucose monitoring (CGM) market. This analysis will include a detailed study into critical issues such as technological developments, geographic trends, market dynamics, adoption trends, competitive intelligence and market revenue forecasts. The report will have product-based segmentation (implanted and minimally/noninvasive methods) and will also have extensive geography based segmentation that will include North America, Europe, Asia and ROW (Rest of World). Intensive segmentations are also included with respect to age, application area, types of diabetes and race.
Increased awareness of the importance of diabetes management among patients has increased adoption levels of continuous glucose monitors. Recent studies have proved the efficiency of CGMs in managing diabetes; this has further encouraged healthcare practitioners to recommend such devices to their patients. However, so far, CGMs are not meant to replace the conventional glucose meters. Emerging innovations therefore have the aim of enhancing precision levels and increasing convenience and usability. Therefore, increased demand coupled with a high level of innovation is making the CGM market extremely dynamic. This report intends to capture such details in great depth to enable effective decision making.
Varsha Bhat has more than five years of experience in market intelligence, business research, strategic consulting and analytics. She has experience in the healthcare domain with respect to pharmaceuticals, pharma chemicals and technologies, and in the life sciences market. Varsha has been constantly tracking, authoring and interacting with top market participants in these domains and has conducted high-level briefings. She has frequently delivered research services that contain high-level analysis, strategic recommendations and top business strategies to enhance the market shares of industry players. She also has extensive experience in training and leading a global research and analytics team. Varsha holds a Bachelor of Science degree in Biotechnology and an MBA in Marketing.